These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9928017)

  • 21. From molecular diversity to catalysis: lessons from the immune system.
    Schultz PG; Lerner RA
    Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid purification of recombinant antibody fragments for catalysis screening.
    Huang H; Fichter B; Dannenbring R; Paul S
    Methods Mol Biol; 1995; 51():403-7. PubMed ID: 7581712
    [No Abstract]   [Full Text] [Related]  

  • 24. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.
    Paul S; Mei S; Mody B; Eklund SH; Beach CM; Massey RJ; Hamel F
    J Biol Chem; 1991 Aug; 266(24):16128-34. PubMed ID: 1874750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of multicatalytic monoclonal antibodies.
    Zein HS; da Silva JA; Miyatake K
    Mol Immunol; 2010 May; 47(9):1747-56. PubMed ID: 20356628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism and functional role of antibody catalysis.
    Paul S
    Appl Biochem Biotechnol; 1998 Oct; 75(1):13-24. PubMed ID: 10214694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice.
    Voice JK; Grinninger C; Kong Y; Bangale Y; Paul S; Goetzl EJ
    J Immunol; 2003 Jan; 170(1):308-14. PubMed ID: 12496414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and catalysis: a thermodynamic study on a catalytic antibody system.
    Wade H; Scanlan TS
    Chembiochem; 2003 Jun; 4(6):537-40. PubMed ID: 12794866
    [No Abstract]   [Full Text] [Related]  

  • 32. VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.
    Bangale Y; Karle S; Planque S; Zhou YX; Taguchi H; Nishiyama Y; Li L; Kalaga R; Paul S
    FASEB J; 2003 Apr; 17(6):628-35. PubMed ID: 12665475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel reactions catalysed by antibodies.
    Golinelli-Pimpaneau B
    Curr Opin Struct Biol; 2000 Dec; 10(6):697-708. PubMed ID: 11114507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain.
    Hifumi E; Nonaka T; Taguchi H; Uda T
    Sci Rep; 2022 Nov; 12(1):19185. PubMed ID: 36357546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalytic hydrolysis of VIP in pregnant women with asthma.
    Olopade CO; Yu J; Abubaker J; Mensah E; Paul S
    J Asthma; 2006 Aug; 43(6):429-32. PubMed ID: 16952860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
    Hotta K; Lange H; Tantillo DJ; Houk KN; Hilvert D; Wilson IA
    J Mol Biol; 2000 Oct; 302(5):1213-25. PubMed ID: 11183784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the catalytic activity of autoantibodies in multiple sclerosis.
    Ponomarenko NA; Durova OM; Vorob'ev II; Suchkov SV; Gabibov AG
    Dokl Biochem Biophys; 2004; 395():120-3. PubMed ID: 15253568
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies as defensive enzymes.
    Paul S; Nishiyama Y; Planque S; Karle S; Taguchi H; Hanson C; Weksler ME
    Springer Semin Immunopathol; 2005 Mar; 26(4):485-503. PubMed ID: 15633014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A complete substitutional analysis of VIP for better tumor imaging properties.
    Bhargava S; Licha K; Knaute T; Ebert B; Becker A; Grötzinger C; Hessenius C; Wiedenmann B; Schneider-Mergener J; Volkmer-Engert R
    J Mol Recognit; 2002; 15(3):145-53. PubMed ID: 12203840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.